Concepedia

Andrea Marchetti

AM

Statistics

Publications

6

Citations

376

H-Index

6

Active since

2001

Affiliations

Azienda USL di Bologna(Current)

Ospedale di Macerata

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Tumori Bari

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Andrea Marchetti is an author at Azienda USL di Bologna specializing in oncology, renal cell carcinoma, and metastatic disease treatment.

ORCID

Publications per year

2001–2024

6

Publications

6

The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study

Veronica Mollica, Alessandro Rizzo, Andrea Marchetti et al. · Clinical and Experimental Medicine · 2023 · 161 citations

, , +14

Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials

Francesco Massari, Alessandro Rizzo, Veronica Mollica et al. · European Journal of Cancer · 2021 · 102 citations

, , +15

Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma

Veronica Mollica, Matteo Santoni, Marc Matrana et al. · Targeted Oncology · 2021 · 75 citations

, , +11

Clinical and economic impact of new trends in glaucoma treatment.

Andrea Marchetti, R Magar, Pei An et al. · PubMed · 2001 · 14 citations

, , +15

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

Francesco Massari, Matteo Santoni, Hideki Takeshita et al. · Cancer Immunology Immunotherapy · 2024 · 14 citations · Full text

, , +17

1–5 of 6